Nektar Therapeutics (NKTR) Misses Q4 EPS by 178c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $65.70 +7.74%
Revenue Growth %: -7.1%
Financial Fact:
Total non-operating expense: -10.18M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -7.1%
Financial Fact:
Total non-operating expense: -10.18M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($1.78). Revenue for the quarter came in at $21.81 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
- Microsoft (MSFT) call put ratio 2.1 calls to 1 put as share price pulls back
- Micron Technology (MU) call put ratio 1 call to 1 put into quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
